瀘天化(000912.SZ):擬11.71億元投建年產10萬噸綠色精細化學品項目
格隆匯2月26日丨瀘天化(000912.SZ)公佈,爲進一步提高四川瀘天化股份有限公司產業鏈優勢,增加公司綜合競爭實力,公司依託瀘州納溪基地合成氨、油脂化工領域的現有產業基礎,不斷延伸產業鏈,向精細化學品發展,擬在瀘州瀘天化化工園區西區投資11.7068億元,建設10萬噸/年綠色精細化學品項目。項目投產後,預計項目投資內部收益率(稅後)爲9.41%,年均銷售收入9.9337億元,年均利潤總額1.0449億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.